{"id":"https://openalex.org/W2068870517","doi":"https://doi.org/10.7326/0003-4819-89-5-838","title":"Process of Developing a New Antimicrobial Drug","display_name":"Process of Developing a New Antimicrobial Drug","publication_year":1978,"publication_date":"1978-11-01","ids":{"openalex":"https://openalex.org/W2068870517","doi":"https://doi.org/10.7326/0003-4819-89-5-838","mag":"2068870517","pmid":"https://pubmed.ncbi.nlm.nih.gov/363004"},"language":"en","primary_location":{"id":"doi:10.7326/0003-4819-89-5-838","doi":"https://doi.org/10.7326/0003-4819-89-5-838","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-89-5-838","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083782304","display_name":"G. Arcieri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"GEORGE ARCIERI","raw_affiliation_strings":["Bloomfield, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bloomfield, New Jersey","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5083782304"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.29019635,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"89","issue":"5_Part_2","first_page":"838","last_page":"841"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.33739998936653137,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.33739998936653137,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14275","display_name":"Historical Medical Research and Treatments","score":0.2671000063419342,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.09910000115633011,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimicrobial-drug-development","display_name":"antimicrobial drug development","score":0.9520000219345093},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.6890000104904175},{"id":"https://openalex.org/keywords/new-drug-application","display_name":"new drug applications","score":0.9139999747276306},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.5540000200271606},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.8009999990463257},{"id":"https://openalex.org/keywords/patient-enrollment","display_name":"patient enrollment","score":0.8460000157356262},{"id":"https://openalex.org/keywords/microbiological-diagnosis","display_name":"microbiological diagnosis","score":0.8870000243186951},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8938082456588745},{"id":"https://openalex.org/C2909960733","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial drug","level":3,"score":0.7797633409500122},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.7502596378326416},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6980995535850525},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.672730565071106},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28256839513778687},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.08286798000335693},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012106","descriptor_name":"Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7326/0003-4819-89-5-838","doi":"https://doi.org/10.7326/0003-4819-89-5-838","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-89-5-838","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},{"id":"pmid:363004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/363004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of internal medicine","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1795471827","https://openalex.org/W2000229845","https://openalex.org/W2079762396","https://openalex.org/W3034460373","https://openalex.org/W2057786049","https://openalex.org/W1012925228","https://openalex.org/W2605677117","https://openalex.org/W2022657122","https://openalex.org/W2046570211","https://openalex.org/W7099137801"],"abstract_inverted_index":{"The":[0,23],"network":[1],"for":[2,60],"development":[3],"of":[4,11,16,35,51,57,79],"a":[5,33],"new":[6,44],"antimicrobial":[7,47],"drug,":[8],"from":[9],"discovery":[10],"the":[12,17,49,61,76],"compound":[13],"to":[14,64],"submission":[15],"New":[18],"Drug":[19],"Application,":[20],"is":[21],"reviewed.":[22],"key":[24],"problems":[25],"encountered":[26],"during":[27],"this":[28],"process,":[29],"as":[30],"elucidated":[31],"through":[32],"survey":[34],"62":[36],"American":[37],"pharmaceutical":[38],"companies,":[39],"include":[40],"difficulties":[41,66],"in":[42,67],"discovering":[43],"and":[45,53,73],"significant":[46],"drugs,":[48],"unpredictability":[50],"in-vitro":[52],"animal":[54],"studies,":[55,72],"lack":[56],"specific":[58],"criteria":[59],"bacteriologic":[62],"response":[63],"therapy,":[65],"setting":[68],"up":[69],"well-controlled":[70],"clinical":[71],"difficulty":[74],"with":[75,82],"timely":[77],"enrollment":[78],"suitable":[80],"patients":[81],"precise":[83],"microbiologic":[84],"diagnosis":[85],"before":[86],"treatment.":[87]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}